Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Molecular Cell|March 5, 2013
AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1Ning Wu, Bin Zheng, Adam Shaywitz, et al.
Cell Metabolism|September 25, 2018
Methodological Issues in Studying PAHSA Biology: Masking PAHSA EffectsIsmail Syed, Jennifer Lee, Odile D Peroni, et al.
Environmental Research|February 16, 2023
Exposure to Volatile Organic Compounds Is Associated with Hypertension in Black Adults: The Jackson Heart StudyKatlyn E McGraw, Stacey L Konkle, Daniel W Riggs, et al.
Traffic (Copenhagen, Denmark)|June 8, 2004
Chemical genetic screening identifies sulfonamides that raise organellar pH and interfere with membrane trafficThomas J F Nieland, Yan Feng, Jing Xu Brown, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 24, 2004
Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritisJanette C Cansick, Rachel Lennon, Carole L Cummins, et al.
Tobacco Induced Diseases|December 18, 2025
Cannabis products and trends in a cohort of young adults: The VapeScan longitudinal studyKatlyn E McGraw, Elizabeth C Oelsner, Nancy J LoIacono, et al.
Journal of Cell Science|December 21, 2023
Regulated dynamic subcellular GLUT4 localization revealed by proximal proteome mapping in human muscle cellsAnuttoma Ray, Jennifer Wen, Lucie Yammine, et al.
Journal of Cardiovascular Pharmacology|October 1, 1993
Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonistG M Olins, V M Corpus, S T Chen, et al.
Molecular Cancer Research : MCR|March 12, 2013
Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumorVirendra K Chaudhri, Gregory G Salzler, Salihah A Dick, et al.
Journal of Medicinal Chemistry|July 23, 1993
Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonistsH C Huang, D B Reitz, T S Chamberlain, et al.
Pageof 17